David Lee
David Lee leads the Autoimmunity, Transplant and Dermatology Translational Medicine group and is responsible for generating and implementing the global disease area TM strategy to efficiently advance Novartis compounds through Proof of Concept to full Development. David joined Novartis in 2010. He led Translational Research in the Autoimmunity, Transplantation and Inflammation disease area between 2010 and December 2011, covering development of target / pathway / mechanism-based assays, identifying target activity in human disease, building pre-clinical rationale for Disease Area compound Proof of Concept studies, and promoting ‘back translation’ of insights from disease cohorts to identify novel targets for drug discovery. Before joining Novartis David was an Associate Professor at Harvard Medical School and Associate Physician at Brigham & Women’s Hospital, focusing on translational studies of autoimmune and inflammatory mechanisms in arthritis. David obtained his medical and graduate degrees from Duke University School of Medicine and post-graduate medical residency and Rheumatology fellowship at Brigham & Women’s Hospital, Harvard Medical School.